Trokendi XR is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Supernus Pharmaceuticals. The primary component is Topiramate.
Product ID | 17772-101_849fe8c8-6088-77c3-e053-2a91aa0ad729 |
NDC | 17772-101 |
Product Type | Human Prescription Drug |
Proprietary Name | Trokendi XR |
Generic Name | Topiramate |
Dosage Form | Capsule, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2013-08-16 |
Marketing Category | NDA / NDA |
Application Number | NDA201635 |
Labeler Name | Supernus Pharmaceuticals |
Substance Name | TOPIRAMATE |
Active Ingredient Strength | 25 mg/1 |
Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2013-08-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA201635 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-08-16 |
Marketing End Date | 2017-10-30 |
Marketing Category | NDA |
Application Number | NDA201635 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-08-16 |
Marketing Category | NDA |
Application Number | NDA201635 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-08-16 |
Marketing End Date | 2019-03-21 |
Marketing Category | NDA |
Application Number | NDA201635 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-08-16 |
Marketing Category | NDA |
Application Number | NDA201635 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-08-16 |
Marketing Category | NDA |
Application Number | NDA201635 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-08-16 |
Ingredient | Strength |
---|---|
TOPIRAMATE | 25 mg/1 |
SPL SET ID: | 2dc7957e-a3e5-46bb-aa66-f3250f872f5e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
17772-104 | Trokendi XR | Trokendi XR |
17772-103 | Trokendi XR | Trokendi XR |
17772-102 | Trokendi XR | Trokendi XR |
17772-101 | Trokendi XR | Trokendi XR |
0245-1071 | QUDEXY | Topiramate |
0245-1072 | QUDEXY | Topiramate |
0245-1073 | QUDEXY | Topiramate |
0245-1074 | QUDEXY | Topiramate |
0245-1075 | QUDEXY | Topiramate |
0093-7335 | Topiramate | Topiramate |
0093-7336 | Topiramate | Topiramate |
0615-7562 | Topiramate | Topiramate |
0615-7563 | Topiramate | Topiramate |
0615-7564 | Topiramate | Topiramate |
0615-7565 | Topiramate | Topiramate |
0615-8138 | Topiramate | Topiramate |
0615-8139 | Topiramate | Topiramate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TROKENDI XR 85644722 4498773 Live/Registered |
Supernus Pharmaceuticals, Inc. 2012-06-06 |